高级检索
当前位置: 首页 > 详情页

A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China [2]Natl Hlth Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China [3]Fudan Univ, Dept Hosp Infect Management, Huashan Hosp, Shanghai, Peoples R China [4]Anhui Med Univ, Clin Microbiol Lab, Affiliated Hosp 1, Hefei, Peoples R China [5]Beijing Hosp, Clin Microbiol Lab, Beijing, Peoples R China [6]Guangzhou Med Univ, Dept Infect Dis, Affiliated Hosp 1, Guangzhou, Peoples R China [7]Guangzhou Med Univ, Clin Microbiol Lab, Affiliated Hosp 1, Guangzhou, Peoples R China [8]Kunming Med Univ, Clin Microbiol Lab, Affiliated Hosp 1, Kunming, Peoples R China [9]Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Infect Dis, Sch Med, Hangzhou, Peoples R China [10]Zhejiang Univ, Sir Run Run Shaw Hosp, Clin Microbiol Lab, Sch Med, Hangzhou, Peoples R China [11]Huazhong Univ Sci & Technol, Clin Microbiol Lab, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China [12]Peking Union Med Coll Hosp, Clin Microbiol Lab, Beijing, Peoples R China [13]Fudan Univ, Clin Microbiol Lab, Childrens Hosp, Shanghai, Peoples R China [14]Shanghai Jiao Tong Univ, Clin Microbiol Lab, Ruijin Hosp, Sch Med, Shanghai, Peoples R China [15]Shanghai Jiao Tong Univ, Dept Hosp Infect Management, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
出处:
ISSN:

关键词: bloodstream infection community-acquired hospital-acquired multicenter investigation antimicrobial susceptibility testing

摘要:
BackgroundBloodstream infections (BSIs), especially hospital-acquired BSIs, are a major cause of morbidity and mortality. However, the details about the pathogens and antimicrobial resistance profile of BSIs across China are still lacking. MethodsAn investigation was conducted in 10 large teaching hospitals from seven geographic regions across China in 2016 based on China Antimicrobial Surveillance Network (CHINET) to profile the clinical and etiological features of BSIs. ResultsA total of 2,773 cases of BSIs were identified, a majority (97.3%) of which were monomicrobial. Overall, 38.4% (1,065/2,773) were community-acquired BSIs (CABSIs), and 61.6% (1,708/2,773) were hospital-acquired BSIs (HABSIs). Of the 2,861 pathogenic BSI isolates, 67.5% were Gram-negative bacteria, 29.6% were Gram-positive bacteria, and 2.9% were fungi. The top BSI pathogens were Escherichia coli, Klebsiella pneumoniae, coagulase-negative Staphylococci (CNS), Staphylococcus aureus, Enterococci, and Acinetobacter baumannii. Escherichia coli and K. pneumoniae isolates showed low susceptibility to penicillins, cephalosporins (except ceftazidime and cefepime), and ampicillin-sulbactam (13.1%-43.4% susceptible); moderate susceptibility (about 60% susceptible) to ceftazidime, cefepime, and aztreonam; and high susceptibility (>90%) to beta-lactam/beta-lactamase inhibitor combinations other than ampicillin-sulbactam, except K. pneumoniae strains to piperacillin-tazobactam (59.2% susceptible). HABSIs were associated with significantly higher prevalence of carbapenem-resistant and extended-spectrum beta-lactamases-producing K. pneumoniae, methicillin-resistant S. aureus, methicillin-resistant CNS, and ampicillin-resistant Enterococci than CABSIs. Overall, 42.0% of the BSI due to S. aureus strains were resistant to methicillin. ConclusionsThe findings about BSIs in teaching hospitals across China add more scientific evidence to inform the appropriate management of the disease.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 免疫学 2 区 微生物学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 免疫学 2 区 微生物学
JCR分区:
出版当年[2020]版:
Q1 MICROBIOLOGY Q2 IMMUNOLOGY
最新[2023]版:
Q1 MICROBIOLOGY Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China [2]Natl Hlth Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
通讯作者:
通讯机构: [1]Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai, Peoples R China [2]Natl Hlth Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:1 总访问量:413 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)